Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Postoperative ctDNA Assessment in Endometrial Cancer Beyond Integrated Genomic Risk Models, Reshaping Precision Decisions for Adjuvant Therapy

NCT07681414 is registered in ClinicalTrials.gov with Guizhou Provincial People's Hospital as lead sponsor.

NCT NCT07681414
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07681414 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Postoperative ctDNA Assessment in Endometrial Cancer Beyond Integrated Genomic Risk Models, Reshaping Precision Decisions for Adjuvant Therapy
Lead sponsor
Guizhou Provincial People's Hospital
Phase
Observational
Overall status
Active, not recruiting
Start date
June 27, 2026
Completion date
December 31, 2026
Enrollment
52 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endometrial cancer